亚洲图片国产日韩欧美_国产区精品欧美日韩在线蜜臀_韩国日本三级在线观看手机视频_影音先锋国产精品无码_亚洲日本va一区二区三区_亚洲精品无码丰满少妇av_天堂在线中文www_扒开粉嫩的小缝开始亲吻男女_尤蜜在线观看免费观看_久久毛片欧洲无码视频

×

本司產(chǎn)品僅用于科研,不用于臨床診斷和治療

全國(guó)免費(fèi)熱線:400-999-2100

您身邊的細(xì)胞培養(yǎng)專家!

所有分類
  • 所有分類
  • 細(xì)胞系
  • 原代細(xì)胞
  • 血清
  • 細(xì)胞培養(yǎng)基
  • 輔助試劑
  • 細(xì)胞凋亡檢測(cè)試劑盒
  • 細(xì)胞房除菌產(chǎn)品
熱搜: 胎牛血清 VERO RAW264.7 成纖維細(xì)胞 間充質(zhì)干細(xì)胞 上皮細(xì)胞

忘記密碼

個(gè)人郵箱:
驗(yàn)證碼: captcha

賬號(hào)激活

個(gè)人郵箱:
×

產(chǎn)品中心Cell Resources

聯(lián)系我們CONTACT US

  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)

AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)

貨號(hào):CL-0602

規(guī)格:1×10?cells/T25培養(yǎng)瓶

價(jià)格: ¥1600

生長(zhǎng)培養(yǎng)基:DMEM/F1210% FBS0.5% ITS-G(100×)+40ng/ml Dexamethasone+1% P/S

數(shù)量: - +

  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
  • AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)

推薦搭配

套餐1:

AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確) ¥1600

細(xì)胞培養(yǎng)最優(yōu)解!

套餐組合價(jià):¥2350¥2450

加入購(gòu)物車

搭配套餐已成功加入購(gòu)物車!

產(chǎn)品概述
產(chǎn)品信息
名稱 AML12 (小鼠正常肝細(xì)胞) (STR鑒定正確)
別稱 AML-12; AML 12; Alpha Mouse Liver 12
種屬 小鼠
生長(zhǎng)特性 貼壁細(xì)胞
細(xì)胞形態(tài) 上皮細(xì)胞樣
凍存條件 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮
培養(yǎng)方案A(默認(rèn))
生長(zhǎng)培養(yǎng)基:
DMEM/F1210% FBS0.5% ITS-G(100×)+40ng/ml Dexamethasone+1% P/S
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
推薦傳代比例 1:4-1:6
推薦換液頻率 2-3次/周
參考資料(來(lái)源文獻(xiàn))
背景描述 The AML12 (alpha mouse liver 12) cell line was established from hepatocytes from a mouse (CD1 strain, line MT42) transgenic for human TGF alpha.
年齡(性別) 雄性;3月齡
組織來(lái)源 肝臟
細(xì)胞類型 自發(fā)永生化細(xì)胞
生物安全等級(jí) BSL-1
倍增時(shí)間 ~37 hours
致瘤性 NO
基因表達(dá)情況 albumin; human transforming growth factor alpha (TGF alpha); mouse TGF alpha.
保藏機(jī)構(gòu) ATCC; CRL-2254 BCRC; 60326 BCRJ; 0354
STR鑒定
  • STR位點(diǎn)信息
    18-3 21
    6-7 12
    5-5 14,15
    X-1 26
    1-2 13
    7-1 29
    8-1 14,15
    1-1 11
    19-2 13
    15-3 21.3
    12-1 19
    6-4 16
    4-2 20.3
    3-2 12
    2-1 9
    13-1

    15.1,15.2

    11-2 18,19
    17-2 14,15
  • STR鑒定圖
參考文獻(xiàn)
文獻(xiàn)列表
  • Cullin-associated and neddylation-dissociated protein 1 (CAND1) alleviates NAFLD by reducing ubiquitinated degradation of ACAA2(2023/08/01)

    作者:Xiang Huang, Xin Liu, Xingda Li

    期刊:Nature Communications

    DOI:10.1038/s41467-023-40327-5

    影響因子 :16.600

    引用產(chǎn)品:CL-0103 CL-0602 CM-0602

  • O-GlcNAcylation of Raptor transduces glucose signals to mTORC1(2023/08/03)

    作者:Chenchen Xu, Xiaoqing Pan, Dong Wang

    期刊:MOLECULAR CELL

    DOI:10.1016/j.molcel.2023.07.011

    影響因子 :16.000

    引用產(chǎn)品:CL-0602 CM-0602

  • Multicomponent microspheres with spatiotemporal drug release for post-surgical liver cancer treatment and liver regeneration(2022/12/01)

    作者:Jinwei Zhong, Qingfei Zhang, Gaizhen Kuang

    期刊:CHEMICAL ENGINEERING JOURNAL

    DOI:10.1016/j.cej.2022.140585

    影響因子 :15.100

    引用產(chǎn)品:CL-0602

  • Synergistic D-Amino Acids Based Antimicrobial Cocktails Formulated via High-Throughput Screening and Machine Learning(2023/12/21)

    作者:Jingzhi Yang, Yami Ran, Shaopeng Liu

    期刊:Advanced Science

    DOI:10.1002/advs.202307173

    影響因子 :15.100

    引用產(chǎn)品:CL-0602

  • Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery(2023/07/01)

    作者:Min Zhao, Zhaokui Jin, Chao Xia

    期刊:BIOMATERIALS

    DOI:10.1016/j.biomaterials.2023.122230

    影響因子 :14.000

    引用產(chǎn)品:CL-0602

  • A chemo/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy(2024/01/09)

    作者:Ning Wang, Qiyu Zhang, Zhuoya Wang

    期刊:CARBOHYDRATE POLYMERS

    DOI:10.1016/j.carbpol.2024.121795

    影響因子 :11.200

    引用產(chǎn)品:CL-0602

  • Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast(2021/11/24)

    作者:Xiang Tao,?Haiqing He,?Jiangtong Peng

    期刊:Pharmacological Research

    DOI:10.1016/j.phrs.2021.106004

    影響因子 :10.334

    引用產(chǎn)品:CL-0602 CM-0602

  • Acute exposure to polystyrene nanoparticles promotes liver injury by inducing mitochondrial ROS-dependent necroptosis and augmenting macrophage-hepatocyte crosstalk(2024/04/12)

    作者:Junjie Fan, Li Liu, Yongling Lu

    期刊:Particle and Fibre Toxicology

    DOI:10.1186/s12989-024-00578-6

    影響因子 :10.000

    引用產(chǎn)品:CL-0602

  • DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy(2023/07/03)

    作者:Liang Zhang, Jiawei Hong, Wei Chen

    期刊:International Journal of Biological Sciences

    DOI:10.7150/ijbs.80351

    影響因子 :9.200

    引用產(chǎn)品:CL-0602

  • Dietary Lactobacillus reuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism(2022/10/18)

    作者:Zishen Lin, Jianmin Wu, Jinping Wang

    期刊:FOOD CHEMISTRY

    DOI:10.1016/j.foodchem.2022.134643

    影響因子 :8.800

    引用產(chǎn)品:CL-0602

  • Human menstrual blood-derived stem cells alleviate autoimmune hepatitis via JNK/MAPK signaling pathway in vivo and in vitro(2023/04/03)

    作者:Fen Zhang, Lanlan Xiao, Ya Yang

    期刊:Frontiers of Medicine

    DOI:10.1007/s11684-022-0953-y

    影響因子 :8.100

    引用產(chǎn)品:CL-0602

  • ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis(2022/10/04)

    作者:Baitong Wu, Jiuxing Feng, Jingyi Guo

    期刊:Stem Cell Research & Therapy

    DOI:10.1186/s13287-022-03049-x

    影響因子 :8.079

    引用產(chǎn)品:CL-0602 CM-M041 CP-M041

  • Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma(2023/01/12)

    作者:Jing Zhang, Haijing Song, Yanan Dong

    期刊:International Journal of Nanomedicine

    DOI:10.2147/IJN.S388916

    影響因子 :8.000

    引用產(chǎn)品:CL-0005 CL-0103 CL-0161 CL-0190 CL-0602

  • Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR(2024/05/07)

    作者:Lin Li, Shuai Xu, Wenyu Wang

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2024.155693

    影響因子 :7.900

    引用產(chǎn)品:CL-0602

  • Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma(2024/03/08)

    作者:Renshun Dong, Tianci Wang, Wei Dong

    期刊:BIOMEDICINE & PHARMACOTHERAPY

    DOI:10.1016/j.biopha.2024.116366

    影響因子 :7.500

    引用產(chǎn)品:CL-0602

  • Dendrobium officinale regulate lipid metabolism in diabetic mouse liver via PPAR-RXR signaling pathway: Evidence from an integrated multi-omics analysis(2024/03/08)

    作者:Junju Zou, Qianbo Song, Pang Chui Shaw

    期刊:BIOMEDICINE & PHARMACOTHERAPY

    DOI:10.1016/j.biopha.2024.116395

    影響因子 :7.500

    引用產(chǎn)品:CL-0602

  • Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway(2024/01/09)

    作者:Ping Chen, Mengqin Yuan, Lichao Yao

    期刊:BIOMEDICINE & PHARMACOTHERAPY

    DOI:10.1016/j.biopha.2024.116133

    影響因子 :7.500

    引用產(chǎn)品:CL-0602

  • FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease(2022/11/03)

    作者:Yajing You, Chenxi Liu, Tiantian Liu, Miaomiao Tian, Nijin Wu, Zhen Yu, Fenglin Zhao, Jianni Qi, Qiang Zhu

    期刊:FREE RADICAL BIOLOGY AND MEDICINE

    DOI:10.1016/j.freeradbiomed.2022.10.322

    影響因子 :7.400

    引用產(chǎn)品:CL-0103 CL-0602

  • Aa-Z2 triggers ROS-induced apoptosis of osteosarcoma by targeting PDK-1(2023/01/07)

    作者:Yixin Liu, Wenyan She, Yi Li

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-022-03862-1

    影響因子 :7.400

    引用產(chǎn)品:CL-0602 PM150710

  • ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance(2023/02/24)

    作者:Caihua Wang, Xiaofang Li, Wei Zhang

    期刊:FREE RADICAL BIOLOGY AND MEDICINE

    DOI:10.1016/j.freeradbiomed.2023.02.017

    影響因子 :7.400

    引用產(chǎn)品:CL-0003 CL-0005 CL-0103 CL-0602

  • Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway(2022/09/10)

    作者:Yaxing Kang, Yiran Song, Yuxin Luo

    期刊:FREE RADICAL BIOLOGY AND MEDICINE

    DOI:10.1016/j.freeradbiomed.2022.08.037

    影響因子 :7.400

    引用產(chǎn)品:CL-0103 CL-0602 PM150312

  • Amphiphilic Rhodamine Fluorescent Probes Combined with Basal Imaging for Fine Structures of the Cell Membrane(2024/04/25)

    作者:Zixu He, Diankai Liu, He Li

    期刊:ANALYTICAL CHEMISTRY

    DOI:10.1021/acs.analchem.4c00946

    影響因子 :7.400

    引用產(chǎn)品:CL-0602

  • Angelica sinensis polysaccharide ameliorates nonalcoholic fatty liver disease via restoring estrogen-related receptor α expression in liver(2023/08/10)

    作者:Li Luo, Huafeng Zhang, Weiliang Chen

    期刊:PHYTOTHERAPY RESEARCH

    DOI:10.1002/ptr.7982

    影響因子 :7.200

    引用產(chǎn)品:CL-0602

  • The Protective Effect of Sericin on AML12 Cells Exposed to Oxidative Stress Damage in a High-Glucose Environment(2022/04/05)

    作者:Feng Ya Jing, Yu Jie Weng, Yu Qing Zhang

    期刊:Antioxidants

    DOI:10.3390/antiox11040712

    影響因子 :7.000

    引用產(chǎn)品:CL-0602

  • Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway(2022/02/10)

    作者:Yi Wang, Bingbing Liu, Peixuan Wu

    期刊:Antioxidants

    DOI:10.3390/antiox11020349

    影響因子 :7.000

    引用產(chǎn)品:CL-0602

  • Targeting PARK7 Improves Acetaminophen-Induced Acute Liver Injury by Orchestrating Mitochondrial Quality Control and Metabolic Reprogramming(2022/10/28)

    作者:Jiao Cai, Deqin Kong, Zi Long

    期刊:Antioxidants

    DOI:10.3390/antiox11112128

    影響因子 :7.000

    引用產(chǎn)品:CL-0602

  • Adipose-Derived Mesenchymal Stem Cells Inhibit JNK-Mediated Mitochondrial Retrograde Pathway to Alleviate Acetaminophen-Induced Liver Injury(2023/01/09)

    作者:Yelei Cen, Guohua Lou, Jinjin Qi

    期刊:Antioxidants

    DOI:10.3390/antiox12010158

    影響因子 :7.000

    引用產(chǎn)品:CL-0602

  • Sappanone A Alleviates the Severity of Carbon Tetrachloride-Induced Liver Fibrosis in Mice(2023/09/04)

    作者:Jing Qi, Lanqian Li, Xueqing Yan

    期刊:Antioxidants

    DOI:10.3390/antiox12091718

    影響因子 :7.000

    引用產(chǎn)品:CL-0190 CL-0560 CL-0602

  • Cannabidiol alleviates perfluorooctane sulfonate-induced macrophage extracellular trap mediate inflammation and fibrosis in mice liver(2023/08/15)

    作者:Dongliu Luo, Jintao Zhang, Hang Yin

    期刊:ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

    DOI:10.1016/j.ecoenv.2023.115374

    影響因子 :6.800

    引用產(chǎn)品:CL-0190 CL-0560 CL-0602

  • Exposure to polystyrene nanoplastics induces hepatotoxicity involving NRF2-NLRP3 signaling pathway in mice(2024/05/09)

    作者:Yiqian Wen, Shiyi Deng, Binhui Wang

    期刊:ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

    DOI:10.1016/j.ecoenv.2024.116439

    影響因子 :6.800

    引用產(chǎn)品:CL-0602

  • Environmental toxin chlorpyrifos induces liver injury by activating P53-mediated ferroptosis via GSDMD-mtROS(2023/04/24)

    作者:Chenyang Han, Jian Sheng, Hongyan Pei

    期刊:ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

    DOI:10.1016/j.ecoenv.2023.114938

    影響因子 :6.800

    引用產(chǎn)品:CL-0602

  • Inhibition of HSPA8 by rifampicin contributes to ferroptosis via enhancing autophagy(2022/10/26)

    作者:Juan Zhou, Yingzheng Tan, Lingli Hu

    期刊:LIVER INTERNATIONAL

    DOI:10.1111/liv.15459

    影響因子 :6.700

    引用產(chǎn)品:CL-0602 CM-0602

  • FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease(2024/01/06)

    作者:Lin Li, Lina Kong, Shuai Xu

    期刊:Hepatology International

    DOI:10.1007/s12072-023-10621-x

    影響因子 :6.600

    引用產(chǎn)品:CL-0602

  • Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease(2023/10/31)

    作者:Shuai Xu, Lina Kong, Lin Li

    期刊:BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

    DOI:10.1016/j.bbadis.2023.166930

    影響因子 :6.200

    引用產(chǎn)品:CL-0602

  • Identification of antioxidant peptides after digestion and absorption of isinglass by serum peptidomics and cellular antioxidant activity analysis(2023/02/10)

    作者:Lanfei Xiao, Yongjun Liang, Geng Liu

    期刊:Food & Function

    DOI:10.1039/D2FO03847A

    影響因子 :6.100

    引用產(chǎn)品:CL-0602 PM150312

  • Mof plays distinct roles in hepatic lipid metabolism under healthy or non-alcoholic fatty liver conditions(2023/11/14)

    作者:Xinghong Guo, Kai Liang, Longqing Xia

    期刊:iScience

    DOI:10.1016/j.isci.2023.108446

    影響因子 :5.800

    引用產(chǎn)品:CL-0602

  • Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo(2024/04/26)

    作者:Yaping Bai, Teng Zhang, Zhengyan Hu

    期刊:BIOCHEMICAL PHARMACOLOGY

    DOI:10.1016/j.bcp.2024.116240

    影響因子 :5.800

    引用產(chǎn)品:CL-0602

  • Isolongifolene alleviates liver ischemia/reperfusion injury by regulating AMPK-PGC1α signaling pathway-mediated inflammation, apoptosis, and oxidative stress(2022/10/17)

    作者:Jinjin Li, Jie Li, Hongbo Fang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2022.109185

    影響因子 :5.600

    引用產(chǎn)品:CL-0602 PM150312

  • Self-assembled FGF21 nanoparticles alleviate drug-induced acute liver injury(2023/01/10)

    作者:Zhiwei Huang, Hengcai Wang, Changju Chun

    期刊:Frontiers in Pharmacology

    DOI:10.3389/fphar.2022.1084799

    影響因子 :5.600

    引用產(chǎn)品:CL-0602

  • Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation(2023/01/04)

    作者:Bin Liu, Jinchao Wang, Guangchuan Wang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2022.109605

    影響因子 :5.600

    引用產(chǎn)品:CL-0602 CM-M041 CP-M041 PB180120 PM150312

  • Trans-anethole pretreatment ameliorates hepatic ischemia–reperfusion injury via regulation of soluble epoxide hydrolase(2023/09/08)

    作者:Jiansen Lu, Wen Hou, Shuang Yang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2023.110809

    影響因子 :5.600

    引用產(chǎn)品:CL-0602 CM-0602

  • Identification of potential pathogenic hepatic super-enhancers regulatory network in high-fat diet induced hyperlipidemia(2024/01/17)

    作者:Yingying Hu, Run Xu, Jing Feng

    期刊:JOURNAL OF NUTRITIONAL BIOCHEMISTRY

    DOI:10.1016/j.jnutbio.2024.109584

    影響因子 :5.600

    引用產(chǎn)品:CL-0602

  • Use of a ferroptosis-related gene signature to construct diagnostic and prognostic models for assessing immune infiltration in metabolic dysfunction-associated fatty liver disease(2023/10/19)

    作者:Xin Lian, Xulei Tang

    期刊:Frontiers in Cell and Developmental Biology

    DOI:10.3389/fcell.2023.1199846

    影響因子 :5.500

    引用產(chǎn)品:CL-0602

  • Qizhu Anticancer Prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes(2024/05/31)

    作者:Rui Hu, Jing Li, Qi Huang

    期刊:JOURNAL OF ETHNOPHARMACOLOGY

    DOI:10.1016/j.jep.2024.118400

    影響因子 :5.400

    引用產(chǎn)品:CL-0602

  • Water extract of earthworms mitigates mouse liver fibrosis by potentiating hepatic LKB1/Nrf2 axis to inhibit HSC activation and hepatocyte death(2023/11/26)

    作者:Tiantian Zhang, Chuo Wang, Anning Song

    期刊:JOURNAL OF ETHNOPHARMACOLOGY

    DOI:10.1016/j.jep.2023.117495

    影響因子 :5.400

    引用產(chǎn)品:CL-0602

  • Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease(2024/01/03)

    作者:Changxu Liu, Zhihao Fang, Kai Yang

    期刊:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

    DOI:10.1111/jcmm.18091

    影響因子 :5.300

    引用產(chǎn)品:CL-0602

  • METTL3 Modulates TXNIP Expression to Affect the Activation of NLRP3 Inflammasome in Hepatic Cells Under Oxygen–Glucose Deprivation/Reperfusion Injury(2024/01/18)

    作者:Yong Zhang, Jianrui Lv, Jian Bai

    期刊:INFLAMMATION

    DOI:10.1007/s10753-023-01958-4

    影響因子 :5.100

    引用產(chǎn)品:CL-0602

  • Adelmidrol ameliorates liver ischemia-reperfusion injury through activating Nrf2 signaling pathway(2023/12/17)

    作者:Min Wu, Xudong Liu, Qiwen Yu

    期刊:EUROPEAN JOURNAL OF PHARMACOLOGY

    DOI:10.1016/j.ejphar.2023.176224

    影響因子 :5.000

    引用產(chǎn)品:CL-0602

  • Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro(2022/02/14)

    作者:Jingquan Ji, Ming Feng, Yan Huang

    期刊:Bioengineered

    DOI:10.1080/21655979.2022.2036902

    影響因子 :4.900

    引用產(chǎn)品:CL-0602

  • 6-Gingerol attenuates hepatic ischemia/reperfusion injury through regulating MKP5-mediated P38/JNK pathway(2024/04/02)

    作者:Qiwen Yu, Jiye Li, Mengwei Cui

    期刊:Scientific Reports

    DOI:10.1038/s41598-024-58392-1

    影響因子 :4.600

    引用產(chǎn)品:CL-0602

  • Skimmianine attenuates liver ischemia/reperfusion injury by regulating PI3K–AKT signaling pathway-mediated inflammation, apoptosis and oxidative stress(2023/10/25)

    作者:Chenglong Huo, Bing Wang, Xuewen Zhang

    期刊:Scientific Reports

    DOI:10.1038/s41598-023-45354-2

    影響因子 :4.600

    引用產(chǎn)品:CL-0602

  • Exploring the mechanism and phytochemicals in Psoraleae Fructus-induced hepatotoxicity based on RNA-seq, in vitro screening and molecular docking(2024/01/19)

    作者:Huiying Shang, Xian Liu, Jinchao Pan

    期刊:Scientific Reports

    DOI:10.1038/s41598-023-50454-0

    影響因子 :4.600

    引用產(chǎn)品:CL-0602

  • Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis(2023/07/08)

    作者:Xiwei Yuan, Lu Li, Ying Zhang

    期刊:Lipids in Health and Disease

    DOI:10.1186/s12944-023-01855-7

    影響因子 :4.500

    引用產(chǎn)品:CL-0103 CL-0602

  • Catalpol inhibits hepatic stellate cell activation by reducing the formation and changing the contents of hepatocyte-derived extracellular vesicles(2022/12/12)

    作者:Zhengyuan Xie, Hengwei Cao, Qing Wang

    期刊:Journal of Cell Communication and Signaling

    DOI:10.1007/s12079-022-00716-9

    影響因子 :4.100

    引用產(chǎn)品:CL-0602

  • BNIP3 in hypoxia-induced mitophagy: novel insights and promising target for non-alcoholic fatty liver disease(2024/01/11)

    作者:Meiyuan Tian, Jing Hou, Zhe Liu

    期刊:INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

    DOI:10.1016/j.biocel.2024.106517

    影響因子 :4.000

    引用產(chǎn)品:CL-0602

  • Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats(2023/06/27)

    作者:Delong Zhen, Lina Ding, Bao Wang

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2023.e17733

    影響因子 :4.000

    引用產(chǎn)品:CL-0602

  • Octreotide ameliorates hepatic ischemia-reperfusion injury through SNHG12/TAF15-mediated Sirt1 stabilization and YAP1 transcription(2022/03/18)

    作者:Shuangfa Zou, Yanhua Peng, Chumei Zheng

    期刊:Toxicology And Applied Pharmacology

    DOI:10.1016/j.taap.2022.115975

    影響因子 :3.800

    引用產(chǎn)品:CL-0602

  • Suppression of SIRT1/FXR signaling pathway contributes to oleanolic acid-induced liver injury(2023/04/05)

    作者:Songjie Liao, Xiaolong Fu, Jianxiang Huang

    期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY

    DOI:10.1016/j.taap.2023.116509

    影響因子 :3.800

    引用產(chǎn)品:CL-0602

  • SIRT5 alleviates hepatic ischemia and reperfusion injury by diminishing oxidative stress and inflammation via elevating SOD1 and IDH2 expression(2022/08/19)

    作者:Daofeng Zheng, Qiwen zeng, Diao He

    期刊:EXPERIMENTAL CELL RESEARCH

    DOI:10.1016/j.yexcr.2022.113319

    影響因子 :3.700

    引用產(chǎn)品:CL-0602 CM-0602

  • Sevoflurane blocks KLF5-mediated transcriptional activation of ITGB2 to inhibit macrophage infiltration in hepatic ischemia/reperfusion injury(2024/05/14)

    作者:Ye Li, Weinian Gao, Shuyan Lei

    期刊:JOURNAL OF GENE MEDICINE

    DOI:10.1002/jgm.3692

    影響因子 :3.500

    引用產(chǎn)品:CL-0602

  • Low?dose ionizing radiation attenuates high glucose?induced hepatic apoptosis and immune factor release via modulation of a miR?155?SOCS1 axis(2023/07/24)

    作者:Hongqiong Fan, Shanshan Liu, Benzheng Jiao

    期刊:Molecular Medicine Reports

    DOI:10.3892/mmr.2023.13058

    影響因子 :3.400

    引用產(chǎn)品:164210 164210-50 CL-0602

  • Running title: AMPK contributes to liver injury(2023/02/27)

    作者:Jianxiang Huang, Songjie Liao, Xiaolong Fu

    期刊:JOURNAL OF APPLIED TOXICOLOGY

    DOI:10.1002/jat.4456

    影響因子 :3.300

    引用產(chǎn)品:CL-0602

  • Inhibition of ROS/caspase-3/GSDME-mediated pyroptosis alleviates high glucose-induced injury in AML-12 cells(2024/05/08)

    作者:Xinrui Wang, Shengying Ye, Linge Tong

    期刊:TOXICOLOGY IN VITRO

    DOI:10.1016/j.tiv.2024.105840

    影響因子 :3.200

    引用產(chǎn)品:CL-0602

  • Circadian rhythm disorders elevate macrophages cytokines release and promote multiple tissues/organs dysfunction in mice(2022/03/02)

    作者:Zhen Sun, Lihua Li, Zhixin Yan

    期刊:Physiol Behav

    DOI:10.1016/j.physbeh.2022.113772

    影響因子 :2.900

    引用產(chǎn)品:CL-0006 CL-0602

  • The augment effects of magnesium hydride on the lipid lowering effect of atorvastatin: an in vivo and in vitro investigation(2024/03/28)

    作者:Wanqiu Chen, Yinyin Zhang, Gen Miao

    期刊:Medical Gas Research

    DOI:10.4103/mgr.MEDGASRES-D-23-00047

    影響因子 :2.900

    引用產(chǎn)品:CL-0602

  • Basic fibroblast growth factor protects against liver ischemia-reperfusion injury via the Nrf2/Hippo signaling pathway(2022/09/08)

    作者:Xixi Chen, Gaozan Tong, Saizhen Chen

    期刊:TISSUE & CELL

    DOI:10.1016/j.tice.2022.101921

    影響因子 :2.600

    引用產(chǎn)品:CL-0602

  • Ganoderic acid A attenuated hepatic impairment by down-regulating the intracellular JAK2-STAT3 signaling pathway in induced mushroom poisoning(2024/01/15)

    作者:Chenggen Xiao, Guoqing Huang, Xiaoxia Cao

    期刊:American Journal of Translational Research

    DOI:PMID:38322557

    影響因子 :2.200

    引用產(chǎn)品:CL-0602

  • HMG-CoA reductase inhibitor from the endophytic fungus Colletotrichum Capsici(2023/11/28)

    作者:Yuanyuan Lu, Qianqian Xu, Liangfang Pang

    期刊:NATURAL PRODUCT RESEARCH

    DOI:10.1080/14786419.2023.2289085

    影響因子 :2.200

    引用產(chǎn)品:CL-0602

  • In vitro and in vivo metabolic profiling of PD105, a PI3Kδ inhibitor, using UHPLC-Q-Exactive Plus-MS(2023/03/06)

    作者:Panhong Wei, Minghai Tang, Ziyan Ma

    期刊:XENOBIOTICA

    DOI:10.1080/00498254.2023.2188070

    影響因子 :1.800

    引用產(chǎn)品:CL-0602

  • 點(diǎn)擊展開(kāi)收起列表
FAQs

Q:{{item.question}}

A:

暫無(wú)數(shù)據(jù)
產(chǎn)品資料
注:百度瀏覽器無(wú)法支持掃一掃功能,請(qǐng)輸入識(shí)別碼,獲取相應(yīng)產(chǎn)品資料

識(shí)別碼示意圖

確定
邱國(guó)娜/胡文君

邱國(guó)娜/胡文君

【 上海 】

何帆

何帆

【 陜西、甘肅、寧夏、青海、新疆 】

 熊經(jīng)理

熊經(jīng)理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

劉本佳

劉本佳

【江蘇(除南京外)】

章臣雄

章臣雄

【 廣州 】

杜焱煒

杜焱煒

【 四川、云南、西藏 】

田博浩

田博浩

【 重慶、貴州 】

石文平

石文平

【 北京、遼寧 】

胡文君

胡文君

【江西】

李榮楓

李榮楓

【 天津、河北、內(nèi)蒙古、山西 】

陳雨蘭

陳雨蘭

【 山東 】

尹國(guó)文

尹國(guó)文

【浙江】

唐小花

唐小花

【 吉林、黑龍江 】

付帥

付帥

【 安徽 】

朱俊宇

朱俊宇

【 河南、廣西 】

李慶祖

李慶祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文強(qiáng)

梅文強(qiáng)

【福建】

林釗光

林釗光

【南京】

微信掃一掃咨詢

微信掃一掃咨詢

在線客服
關(guān)閉
在線咨詢
聯(lián)系銷售

關(guān)注微信公眾號(hào)